C-N-Bond-Forming ReductiVe Elimination
J. Am. Chem. Soc., Vol. 119, No. 35, 1997 8243
1H NMR: (C6D6) δ 3.28 (s, 3H), 3.66 (m, 2H), 3.71 (m, 2H), 3.93 (m,
2H), 4.53 (m, 2H), 6.44 (d, 6.7 Hz, 2H), 6.80-7.09 (m, 14H), 7.40-
7.46 (m, 4H), 8.34-8.39 (m, 4H). 31P{1H} NMR: (C6D6) δ 29.4 (d,
32.4 Hz), 8.9 (d, 32.4 Hz).
Preparation of (DPPF)Pd(p-CH3C6H4)(I). Using the general
procedure with 248 mg (0.292 mmol) of trans-(PPh3)2Pd(p-CH3C6H4)-
(I) and 178 mg (0.321 mmol) of DPPF gave 208 mg (81%) of product.
1H NMR: (C6D6) δ 2.04 (s, 3H), 3.65 (m, 2H), 3.72 (m, 2H), 3.93 (m,
2H), 4.50 (m, 2H), 6.52 (d, 6.6 Hz, 2H), 6.81-7.12 (m, 14H), 7.39-
7.45 (m, 4H), 8.28-8.34 (m, 4H). 31P{1H} NMR: (C6D6) δ 25.1 (d,
34.8 Hz), 8.0 (d, 34.8 Hz).
Preparation of (DPPF)Pd(p-CH3SC6H4)(Br). Using the general
procedure with 260 mg (0.309 mmol) of trans-(PPh3)2Pd(p-CH3SC6H4)-
(I) and 188 mg (0.340 mmol) of DPPF gave 218 mg (81%) of product.
1H NMR: (CDCl3) δ 3.72 (m, 2H), 4.16 (m, 2H), 4.50 (m, 2H), 4.66
(m, 2H), 6.55 (d, 6.7 Hz, 2H), 6.84-6.89 (m, 2H), 7.15-7.26 (m, 4H),
7.34-7.50 (m, 12H), 8.01-8.05 (m, 4H). 31P{1H} NMR: (C6D6) δ
29.4 (d, 33.0 Hz), 9.2 (d, 33.0 Hz).
Preparation of (DPPF)Pd(p-ClC6H4)(I). Using the general pro-
cedure with 240 mg (0.276 mmol) of trans-(PPh3)2Pd(p-ClC6H4)(I) and
168 mg (0.304 mmol) of DPPF gave 226 mg (91%) of product. 1H
NMR: (CDCl3) δ 2.28 (s, 3H), 3.64 (m, 2H), 4.16 (m, 2H), 4.50 (m,
2H), 4.68 (m, 2H), 6.60 (d, 7.3 Hz, 2H), 6.86-9.82 (m, 2H), 7.13-
7.18 (m, 4H), 7.29-7.50 (m, 12H), 8.03-8.10 (m, 4H). 31P{1H}
NMR: (C6D6) δ 25.2 (d, 33.0 Hz), 8.7 (d, 33.0 Hz).
5.3 Hz), 73.97 (d, 32.3 H), 74.97 (d, 8.8 Hz) 75.48 (d, 10.6 Hz), 79.34
(dd, 40.4 Hz, 6.3 Hz), 113.61 (d, 8.8 Hz), 122.17 (s), 123.18 (s), 127.72
(d, 9.3 Hz), 127.93 (d,9.3 Hz), 128.26 (s), 128.81 (s), 129.99 (d, 17.9
Hz), 133.33 (d, 50.3 Hz), 134.86 (d, 11.5), 135.41 (d, 13.3), 135.44
(d, 32.4 Hz), 136.62 (d, 2.8 Hz), 142.74 (dd, 124.3 Hz, 9.0 Hz), 147.41
(s), 153.45 (s). 31P{1H} NMR: (toluene) δ 14.1 (d, 33.4 Hz), 23.1 (d,
33.4 Hz). Anal. Calcd for C56H52FeN2P2Pd: C, 68.83; H, 5.36; N,
2.87. Found: C, 69.22; H, 5.48; N, 2.61.
Preparation of (DPPF)Pd(p-CH3OC6H4)[N(p-CH3C6H4)2] (3c).
Following the procedure for the preparation of 3a, (DPPF)Pd(p-CH3-
OC6H4)(I) (180 mg. 0.201 mmol) was reacted with KN(p-CH3C6H4)2
(52 mg, 0.221 mmol) in THF. Recrystallization at -35 °C from a
concentrated THF solution layered with ether gave 143 mg of pure 3c
(74%). 1H NMR: (C6D6) δ 2.23 (s, 6H), 3.17 (s, 3H), 3.72 (m, 2H),
3.95 (m, 2H), 4.15 (m, 2H), 4.50 (m, 2H), 6.26 (d, 8.1 Hz, 2H), 6.85
(d, 8.1 Hz, 2H), 6.90 (d, 8.2 Hz, 4H), 6.99-7.10 (m, 12H), 7.35 (d,
8.2 Hz, 4H), 7.62-7.69 (m, 4H), 7.80-7.86 (m, 4H). 13C{1H} NMR:
(C6D6) δ 20.98 (s), 54.40 (s), 72.18 (d, 5.6 Hz), 73.35 (d, 5.2 Hz),
73.91 (d, 33.1 Hz), 74.94 (d, 9.2 Hz), 75.54 (d, 12.9 Hz), 79.08 (dd,
41.4 Hz, 7.0 Hz), 112.90 (d, 8.8 Hz), 122.13 (s), 123.38 (s), 127.72 (d,
9.4 Hz), 127.99 (d, 11.4 Hz), 128.24 (s), 128.83 (s), 130.12 (d, 3.8
Hz), 133.01 (d, 51.3 Hz), 134.75 (d, 12.5 Hz), 135.27 (d, 34.3 Hz),
135.36 (d, 12.5 Hz), 136.68 (d, 3.8 Hz), 146.68 (dd, 124.2 Hz, 9.6
Hz), 153.30 (s), 156.54 (s). 31P{1H} NMR: (toluene) δ 23.2 (d, 33.5
Hz), 14.6 (d, 33.5 Hz). Anal. Calcd for C55H49FeNOP2Pd: C, 68.51;
H, 5.12; N, 1.45. Found: C, 68.22; H, 4.98; N, 1.29.
Preparation of (DPPF)Pd(p-CH3C6H4)[N(p-CH3C6H4)2] (3d).
Following the procedure for the preparation of 3a, (DPPF)Pd(p-
CH3C6H4)(I) (158 mg. 0.180 mmol) was reacted with KN(p-CH3C6H4)2
(52 mg, 0.221 mmol) in THF. Recrystallization at -35 °C from a
concentrated THF solution layered with ether gave 116 mg of pure 3d
(68%). 1H NMR: (C6D6) δ 1.94 (s, 3H), 2.23 (s, 6H), 3.73, (m, 2H),
3.95 (m, 2H), 4.16 (m, 2H), 4.48 (m, 2H), 6.40 (d, 6.3 Hz, 2H), 6.89-
6.93 (m, 6H), 7.00-7.10 (m, 12H), 7.34 (d, 8.3 Hz, 4H), 7.62-7.66
(m, 4H), 7.81-7.85 (m, 4H); 31P{1H} NMR: (toluene) δ 23.6 (d, 34.2
Hz), 14.6 (d, 34.2 Hz). Anal. Calcd for C55H49FeNP2Pd: C, 69.67;
H, 5.21; N, 1.48. Found: C, 69.88; H, 5.42; N, 1.21.
Preparation of (DPPF)Pd(p-CH3SC6H4)[N(p-CH3C6H4)2] (3e).
Following the procedure for the preparation of 3a, (DPPF)Pd(p-CH3-
SC6H4)Br (210 mg. 0.241 mmol) was reacted with KN(p-CH3C6H4)2
(52 mg, 0.221 mmol) in THF. Recrystallization at -35 °C from a
concentrated THF solution layered with ether gave 158 mg of pure 3e
(67%). 1H NMR: (C6D6) δ 1.92 (s, 3H), 2.28 (s, 6H), 3.72 (m, 2H),
3.94 (m, 2H), 4.16 (m, 2H), 4.47 (m, 2H), 6.58 (d, 6.0 Hz, 2H), 6.83-
7.10 (m, 18H), 7.31 (d, 8.2 Hz, 4H), 7.60-7.74 (m, 4H), 7.76-7.84
(m, 4H). 13C{1H} NMR: (C6D6) δ 20.96 (s), 21.37 (s), 72.29 (d, 5.4
Hz), 73.42 (d, 5.4 Hz), 73.78 (d, 35.7 Hz), 74.96 (d, 9.0 Hz), 75.55 (d,
13.0 Hz), 78.61 (dd, 41.6 Hz, 7.1 Hz), 122.16 (s), 123.56 (s), 125.63
(s), 126.43 (d 7.8 Hz), 127.82 (d 8.7 Hz), 128.34 (d, 11.6 Hz), 128.63
(s), 128.86 (s), 129.24 (s), 130.21 (s), 132.77 (d, 50.4 Hz), 134.62 (d,
11.0 Hz), 135.10 (d, 37.2 Hz), 136.88 (s), 153.19 (s), 156.02 (dd, 127.6
Hz, 7.3 Hz). 31P{1H} NMR: (toluene) δ 23.4 (d, 34.8 Hz), 14.6 (d,
34,8 Hz). Anal. Calcd for C55H49FeNP2PdS: C, 67.39; H, 5.04; N,
1.43. Found: C, 67.02; H, 4.91; N, 1.74.
Preparation of (DPPF)Pd(p-NMe2C6H4)(Br). {[P(o-tolyl)3](p-
27
NMe2C6H4)Pd(µ-Br)}2 (240 mg, 0.197 mmol) was suspended in 4
mL of THF. DPPF (240 mg, 0.433 mmol) was added to the stirred
suspension as a solid. The reaction was allowed to stir at room
temperature for 10 min. The product was precipitated by the addition
of 15 mL of pentane. The product was collected as a solid by filtration
on a fritted glass funnel to yield 281 mg (83%). The product was
used without further purification. 1H NMR: (C6D6) δ 2.46 (s, 6H),
3.67 (m, 2H), 3.74 (m, 2H), 3.93 (m, 2H), 4.53 (m, 2H), 6.30 (d, 7.0
Hz, 2H), 6.85-7.06 (m, 14H), 7.44-7.50 (m, 4H), 8.35-8.41 (m, 4H).
31P{1H} NMR: (C6D6) δ 29.2 (d, 33.6 Hz), 8.5 (d, 33.6 Hz).
Preparation of (DPPF)Pd(C6H5)[N(p-CH3C6H4)2] (3a). (DPPF)-
Pd(C6H5)(I) (174 mg, 0.201 mmol) was suspended in 15 mL of toluene.
KN(p-CH3C6H4)2 (52 mg, 0.221 mmol) was added to the solution as a
solid. The reaction was stirred at room temperature for 30 min, and it
turned a deep red color. The reaction mixture was filtered through
Celite, and the toluene was removed under vacuum. The resulting solid
was dissolved in 8 mL of THF. The THF solution was concentrated
under vacuum and layered with Et2O. Pure crystalline material was
obtained by cooling the layered solution at -35 °C for 12 h. The yield
of 3a was 129 mg (69%). 1H NMR: (C6D6) δ 2.23 (s, 6H), 3.72 (m,
2H), 3.94 (m, 2H), 4.15 (m, 2H), 4.48 (m, 2H), 6.55 (m, 3H), 6.89 (d,
8.2 Hz, 4H), 7.00-7.06 (m, 14H), 7.32 (d, 8.2 Hz), 4H, 7.65 (m, 4H),
7.83 (m, 4H). 13C{1H} NMR: (C6D6) δ 20.98 (s), 72.22 (d, 6.1 Hz),
73.38 (d, 5.6 Hz), 73.85 (d, 34.1 Hz), 74.98 (d, 8.9 Hz), 75.56 (d, 11.3
Hz), 78.97 (dd, 41.3 Hz, 8.9 Hz), 121.98 (s), 123.45 (s), 126.25 (d, 8.8
Hz), 127.51 (d, 9.1 Hz), 127.81 (d, 9.6 Hz), 128.05 (s), 128.62 (s),
129.91 (s), 129.91 (s), 132.89 (d, 49.9 Hz), 134.45 (d, 11.8 Hz), 135.15
(d, 12.9 Hz), 135.26 (d, 34.2 Hz), 136.40 (s), 153.30 (s), 158.80 (dd,
121.2 Hz, 8.1 Hz). 31P{1H} NMR: (THF) δ 23.5 (d, 35.4 Hz), 14.9
(d, 35.4 Hz). IR (cm-1): (KBr) 3051 (m), 3010 (m), 2908 (m), 2854
(m), 1598 (s), 1566 (s), 1549 (s), 1490 (s), 1432 (m), 1389 (s), 1314
(s), 1292 (m), 1259 (s), 1219 (s), 1200 (w), 1170 (w), 1098 (m), 1063
(s), 1016 (s), 995 (m), 899 (w), 886 (w), 866 (m), 839 (m), 829 (m),
809 (s), 799 (s), 772 (s), 746 (s), 728 (s), 691 (m), 638 (w), 631 (w),
587 (w), 565 (m), 540 (s), 514 (s), 488 (m), 159 (m). Anal. Calcd for
C54H47FeNP2Pd: C 69.43, H 5.07, N 1.50. Found: C 69.18, H 4.93,
N 1.25.
Preparation of (DPPF)Pd(p-ClC6H4)[N(p-CH3C6H4)2] (3f). Fol-
lowing the procedure for the preparation of 3a, (DPPF)Pd(p-ClC6H4)-
(I) (176 mg. 0.196 mmol) was reacted with KN(p-CH3C6H4)2 (51 mg,
0.217 mmol) in THF. Recrystallization at -35 °C from a concentrated
THF solution layered with ether gave 118 mg of pure 3f (62%). 1H
NMR: (C6D6) δ 2.22 (s, 6H), 3.70 (m, 2H) 3.94 (m, 2H), 4.13, (m,
2H), 4.45 (m, 2H), 6.57 (d, 6.7 Hz, 2H), 6.83-6.88 (m, 6H), 6.98-
7.10 (m, 12H), 7.27 (d, 8.2 Hz, 4H), 7.55-7.62 (m, 4H), 7.75-7.82
(m, 4H). 13C{1H} NMR: (C6D6) δ 20.92 (s) 72.29 (d, 5.5 Hz), 73.42
(d, 7.9 Hz), 73.78 (d, 34.3 Hz), 74.91 (d, 8.6 Hz), 75.61 (d, 11.1 Hz),
78.38 (dd. 43.4 Hz, 8.2 Hz), 122.11 (s), 123.77 (s), 126.12 (d, 8,5 Hz),
127.73 (d, 8.5 Hz), 127.89 (s), 128.13 (d, 11.8 Hz), 128.25 (s), 128.88
(s), 130.29 (d, 11.8 Hz), 132.50 (d, 50.5 Hz), 134.51 (d, 11.4 Hz),
134.91 (d, 36.4 Hz), 135.31 (d, 12.8 Hz), 137.46 (s), 153.03 (s), 157.05
(dd, 125.2 Hz, 8.5 Hz). 31P{1H} NMR: (toluene) δ 23.5 (d, 34.2 Hz),
15.2 (d, 34.2 Hz); Anal. Calcd for C54H46ClFeNP2Pd: C, 66.96; H,
4.79; N, 1.45. Found: C, 66.74; H, 4.95; N, 1.30.
Preparation of (DPPF)Pd(p-NMe2C6H4)[N(p-CH3C6H4)2] (3b).
Following the procedure for the preparation of 3a, (DPPF)Pd(p-
NMe2C6H4)(Br) (180 mg, 0.209 mmol) was reacted with KN(p-
CH3C6H4)2 (52 mg, 0.221 mmol) in THF. Recrystallization at -35
°C from a concentrated THF solution layered with ether gave 159 mg
of pure 3b (78%). 1H NMR: (C6D6) δ 2.24(s, 6H), 2.37 (s, 6H), 3.74
(m, 2H), 3.95 (m, 2H), 4.17 (m, 2H), 4.49 (m, 2H), 6.10 (d, 7.1 Hz,
2H), 6.84 (t, 7.9 Hz, 2H), 6.90 (d, 8.2 Hz, 4H), 7.00-7.07 (m, 12H),
7.36 (d, 8.2 Hz, 4H), 7.66-7.70 (m, 4H), 7.83-7.86 (m, 4H). 13C-
{1H} NMR: (C6D6) δ 21.00 (s), 41.03 (s), 72.13 (d, 5.6 Hz), 73.28 (d,
Preparation of (PPh3)Pd(C6H4-C6H4NH2)(I) (4). Into a 50 mL
screw-capped test tube, 602 mg (0.522 mmol) of Pd[P(C6H5)3]4 was